Loading...
Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure
Support measures currently represent the mainstay of treatment for fulminant myocarditis, while effective and safe anti-inflammatory therapies remain an unmet clinical need. However, clinical and experimental evidence indicates that inhibition of the pro-inflammatory cytokine interleukin 1 (IL-1) is...
Na minha lista:
| Udgivet i: | Front Immunol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5298961/ https://ncbi.nlm.nih.gov/pubmed/28232838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00131 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|